DNA修复基因单核苷酸多态性在肿瘤化疗敏感性预测的应用进展
被引量:4
出处
《临床肿瘤学杂志》
CAS
2008年第1期88-92,共5页
Chinese Clinical Oncology
基金
全军医学科学技术研究“十一五”计划基金(06MA111)
江苏省自然科学基金前期预演项目(BK2005203)
南京市医学科技发展项目(ZKX0427)
参考文献35
-
1Wood RD, Mitchell M, Sgouros J, et al. Human DNA repair genes [J]. Science, 2001,291(5507): 1284-1289.
-
2Shi MM. Enabling large-scale pharmacogenetic studies by high throughput mutation detection and genotyping technologies [ J]. Clinical Chemistry, 2001,47(2) :164.
-
3Savas S, Kim DY, Ahmad MF, et al. Identifying functional genetic variants in DNA repair pathway using protein conservation analysis [J]. Cancer Epidemiol Biomarkers Prey, 2004, 13(5) : 801 - 807.
-
4Mollemann M, Wolter M, Felsberg J, et al. Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors [J]. lnt J Cancer, 2005,20;113(3) : 379 - 385.
-
5Rood BR, Zhang H, Cogen PH. Intercellular heterogeneity of expression of the MGMT DNA repair gene in pediatric medulloblastoma [J]. Neuro-oncol, 2004, 6(3) : 200 -207.
-
6Okamoto R, Takano H, Okamura T, et al. O^6-methylguanineDNA methyhransferase (MGMT) as a determinant of resistance to camptothecin derivatives [ J]. Jpn J Cancer Res, 2002, 93 ( 1 ) : 93 - 102.
-
7Hao B, Wang H, Zhou K, et al. Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma [ J ]. Cancer Res, 2004, 64 (12) : 4378 -4384.
-
8Stoehlmacher J, Ghaderi V, Iobal S, et al. A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer [ J ]. Anticancer Res, 2001, 21 (4B) : 3075 -3079.
-
9王中华,缪小平,谭文,张湘茹,徐兵河,林东昕.XRCC1单核苷酸多态与晚期非小细胞肺癌对铂类药物化疗敏感性的相关性[J].癌症,2004,23(8):865-868. 被引量:56
-
10Gurubhagavatula S, Liu G, Park S, et al. XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-smallcell lung cancer patients treated with platinum chemotherapy [J]. J Clin Oncol, 2004, 22(13): 2594-2601.
二级参考文献15
-
1Risch NJ. Searching for genetic determinants in the new millennium [J]. Nature,2000,405:847- 856.
-
2Weinshilboum R. Inheritance and drug response [J]. N Engl J Med,2003,348:529- 537.
-
3Reed E. Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy [J]. Cancer Treat Rev,1998,24:331- 344.
-
4Rosell R,Lord RV,Taron M,et al. DNA repair and cisplatin resistance in non-small-cell lung cancer [J]. Lung Cancer,2002,38:217- 227.
-
5Lunn RM,Langlois RG,Hsieh LL,et al. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency [J]. Cancer Res,1999,59:2557- 2561.
-
6Schiller JH,Harrington D,Belani CP,et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer [J]. N Engl J Med,2002,346:92- 98.
-
7Zatloukal P,Petruzelka L,Zemanova M,et al. Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage Ⅲ b and Ⅳ non-small cell lung cancer: a phase Ⅲ randomized trial [J]. Lung Cancer,2003,41:321- 331.
-
8Xing D,Qi J,Lin D,et al. Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population [J]. Int J Cancer,2002,100:600- 605.
-
9Xing D,Tan W,Lin D. Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population(review)[J].Oncol Rep,2003,10:1615- 1623.
-
10Duell EJ,Millikan RC,Pittman GS,et al. Polymorphisms in the DNA repair gene XRCC1 and breast cancer [J]. Cancer Epidemiol Biomarkers Prev,2001,10:217- 222.
共引文献62
-
1杨宏,何敏,武家,杜家乐,张翠英.肺癌组织中HIF-1a及VEGF表达水平与盐酸埃克替尼靶向治疗效果及临床预后的关系[J].中华转移性肿瘤杂志,2018(1):43-47. 被引量:1
-
2邓清华,苏丹,马胜林,刘鹏,张毅敏,姜志明,李单.碱基切除修复基因单核苷酸多态性和晚期非小细胞肺癌治疗疗效研究[J].肿瘤研究与临床,2007,19(7).
-
3陆爱国,冯波,郑民华,许国旺.毛细管电泳联合激光诱导荧光技术检测结直肠癌hMLH1基因突变[J].临床检验杂志,2005,23(1):25-27. 被引量:2
-
4冷曙光,何云,庄志雄,郑玉新.外源性化学物致机体DNA损伤与修复的生物标志物研究进展[J].中华预防医学杂志,2005,39(3):210-212. 被引量:5
-
5范凯,马坚妹,王彦,吕申.散发性大肠癌错配修复基因hMLH1的突变及甲基化研究[J].癌变.畸变.突变,2005,17(3):167-170. 被引量:3
-
6袁芃,缪小平,张雪梅,王中华,谭文,张湘茹,孙燕,徐兵河,林东昕.核苷酸切除修复系统基因遗传多态与晚期非小细胞肺癌患者铂类药物敏感性关系[J].癌症,2005,24(12):1510-1513. 被引量:46
-
7王中华,徐兵河,梁刚,张湘茹,谭文,缪小平,林东昕.DNA修复基因XRCC1单核苷酸多态性与晚期非小细胞肺癌铂类药物化疗后生存期的关系[J].中国综合临床,2006,22(1):1-3. 被引量:14
-
8冯波,郑民华,陆爱国,李健文,江唯娜,王明亮,马君俊,董峰,石先哲,许国旺.D(E/')TECTION DE LA MUTATION DU G(E/')NE HMLH1 DANS LE CANCER COLO-RECTAL PAR(E/')LECTROPHOR(E/')SE CAPILAI-LRE ASSOCI(E/')E (A/') LA FLUORESCENCE LASER-INDUITE[J].Journal of Shanghai Second Medical University(Foreign Language Edition),2006,18(1):20-25.
-
9袁芃,林东昕,缪小平,张雪梅,王中华,谭文病,张湘茹,孙燕,徐兵河.晚期非小细胞肺癌对铂类药物的化疗敏感性与p53和p73基因多态的关系[J].中华肿瘤杂志,2006,28(2):107-110. 被引量:17
-
10苏丹,马胜林.DNA修复基因预测非小细胞肺癌放化疗敏感性[J].国际肿瘤学杂志,2006,33(5):361-363. 被引量:1
同被引文献31
-
1林莉,刘晓晴,宋三泰.DNA损伤修复与铂类耐药研究进展[J].中国肿瘤,2006,15(1):29-31. 被引量:29
-
2魏履新.阳江高本底辐射地区流行病学研究概述(1986—2004年阶段)[J].辐射防护通讯,2006,26(3):1-5. 被引量:7
-
3娄毅,宋清斌,何向民.东北地区汉族人群DNA修复基因XPD单核苷酸多态性与胃癌的相关性[J].世界华人消化杂志,2006,14(32):3143-3146. 被引量:11
-
4王威,夏昭林.人类基因组单核苷酸多态性研究与疾病三级预防体系[J].国外医学(卫生学分册),2006,33(6):321-325. 被引量:5
-
5孙燕,周爱萍,王燕,马建辉.临床肿瘤学进展——回眸2006年[J].癌症进展,2007,5(1):3-8. 被引量:7
-
6刘琳,刘杰,王哲海,宋宝,郭珺.XPD基因遗传多态与晚期结直肠癌患者化疗后生存期的关系[J].山东医药,2007,47(10):62-63. 被引量:2
-
7Goldberg RM, Meropol N J, Tabernero J, et al. Accomplishments in 2008 in the treatment of advanced metastatic colorectal cancer [J]. Gastrointest Cancer Res, 2009, 3(Suppl 2):23-27.
-
8O' connell J B, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging[J]. Nat I Cancer Inst, 2004,96(6) : 1420-1425.
-
9Gan Y, Li XR, Chen DJ, et al. Association between polymor- phisms of XRCC1 Arg399Gln and XPD Lys751Gln genes and prognosis of colorectal cancer in a Chinese populationFJ:. Asian Pac J Cancer Prev, 2012,13(11) : 5721-5724.
-
10Lamas MJ, Duran G, Balboa E, et al. Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-oxalipla- tin regimen in patients with metastatic colorectal cancer [J]. Pharmacogenomics, 2011,12(3) :433-442.
引证文献4
-
1陈雅敏,刘基巍,祁楠,曲鸿翔.DNA修复基因XPD751单核苷酸多态性与结直肠癌化疗疗效的相关性[J].肿瘤防治研究,2010,37(11):1292-1295.
-
2陈雅敏,刘基巍,张昉.结直肠癌基因XPD751和XPD312单核苷酸多态性与FOLFOX方案疗效相关性分析[J].中华肿瘤防治杂志,2014,21(24):1946-1951. 被引量:6
-
3陈慧峰,李晓杰,赵雷,温薇,李小亮,刘明,闫雪华,苏世标.广东省高本底地区汉族人群MGMT基因遗传多态性分布[J].中国职业医学,2015,42(6):615-619. 被引量:1
-
4陈慧峰,闫雪华,赵雷,蔡学立,陈惠清,王烁.广东省氡辐射地区人群hOGG1基因5'侧翼区遗传多态性分布[J].中国职业医学,2017,44(6):671-676. 被引量:1
二级引证文献8
-
1邱模勤,于祥远,秦林原,王倩倩,李强,贝春华,曾小云,仇小强,彭涛,黎乐群,余红平.Met基因单核苷酸多态性与肝细胞癌易感性关系研究[J].中华肿瘤防治杂志,2015,22(21):1649-1653. 被引量:1
-
2陆蓉,李俊蕾,贾平,陈蓉.快速康复外科辅助FOLFOX化疗方案对结直肠癌患者术后恢复、并发症及生存质量的影响[J].中国药房,2016,27(27):3774-3776. 被引量:27
-
3方钱,徐洪根,邵春法,马进.抗癌平丸对结直肠癌术后FOLFOX方案化疗患者的临床疗效[J].中国生化药物杂志,2017,37(2):93-96. 被引量:10
-
4闫寒冰,樊华.DNA修复基因XPD与肿瘤关系的研究进展[J].医学综述,2017,23(4):680-683. 被引量:1
-
5陈慧峰,闫雪华,赵雷,蔡学立,陈惠清,王烁.广东省氡辐射地区人群hOGG1基因5'侧翼区遗传多态性分布[J].中国职业医学,2017,44(6):671-676. 被引量:1
-
6杨光,王莹,刘璐,王彦荣.奥沙利铂治疗晚期左右半结肠癌疗效观察[J].医学食疗与健康,2018,0(5):64-64. 被引量:2
-
7陈慧峰,张金鑫,闫雪华,赵雷,黎丽春,邹剑明.广东省氡辐射地区人群h OGG1基因5'侧翼区多态性单体型分析[J].中国职业医学,2018,45(5):548-552. 被引量:1
-
8乔青,刘娟,王爱鑫,余丹绯,苟福胜,林志宇,冷政伟.XPD 751基因单核苷酸多态性与结肠癌术后mFOLFOX6化疗疗效及预后的关系[J].中华普通外科学文献(电子版),2020,14(2):103-106. 被引量:2
-
1刘新帆,殷蔚伯,谷铣之.肿瘤放射敏感性预测PCC+FISH方法[J].中华放射肿瘤学杂志,1997,6(2):122-124. 被引量:2
-
2徐庚达,周顺泉,高敏,赵阳,杜子威.人体肿瘤体外培养药物敏感性预测及其应用[J].肿瘤,1992,12(4):175-177. 被引量:2
-
3王莉,刘风花,刘若男.宫颈鳞癌新辅助化疗敏感性预测指标的研究[J].中国肿瘤,2005,14(9):622-624. 被引量:1
-
4王丽莎(综述),杜祥(审校).局部晚期直肠癌新辅助治疗及其敏感性预测的研究进展[J].中国癌症杂志,2010,20(12):946-950. 被引量:9
-
5张英男,王秀清,郑向鹏,郑涛,郭一玲,陈伟.^(99m)Tc-MIBI肺肿瘤显像对肺癌化疗敏感性预测的研究[J].中国临床医学影像杂志,2002,13(3):179-181. 被引量:5
-
6张冠南,王保华,肖毅,邱辉忠.直肠癌新辅助放化疗敏感性预测进展[J].癌症进展,2009,7(3):250-254.
-
7王莉,刘风花,刘若男.宫颈鳞癌新辅助化疗敏感性预测指标研究[J].医药论坛杂志,2004,25(20):15-16. 被引量:5
-
8崔玖洁,李苏宜.食管癌化疗敏感性预测及预后分子靶点研究进展[J].癌症进展,2010,8(2):143-147. 被引量:4
-
9裴海平,裴谦,伍韶斌,朱红.直肠癌术前个体化同步放化疗敏感性研究[J].中华胃肠外科杂志,2014,17(6):565-569. 被引量:7
-
10田君(综述),姚学权,刘福坤(审校).直肠癌新辅助放疗及其敏感性预测的研究进展[J].肿瘤研究与临床,2014,26(3):212-215. 被引量:5